drugset / Trial / NCT04946474

Clinical Evaluation of the Combination of Symptoms and Symptoms With General Treatment for Acute Hemorrhagic Stroke

NCT04946474 ↗

Non-randomizedParallel-groupSingle-blindTreatment

Summary

Objective To evaluate whether Xingnaojing injection combined with Naoxueshu oral liquid can significantly improve the clinical outcome of patients with intracerebral hemorrhage. Secondary objectives included to evaluate whether combined application of Xingnaojing injection and Naoxueshu oral liquid can promote hematoma absorption or reduce perihematoma cerebral edema in patients with intracerebral hemorrhage

Timeline

Start
2019-06-01
Primary completion
2020-07-01
Completion
2021-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Shuxuetong Traditional medicine (herbal / TCM) — Oral
Subject Xingnaojing Unknown — —